Genentech Exec Heads East To Take The Reins Of Cancer-Focused Start-up Agios

Calling it “the right time and the right opportunity,” Genentech’s cancer drug development expert David Schenkein plans to move on.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet